|Year : 2011 | Volume
| Issue : 2 | Page : 130-134
Immunomodulatory and erythropoietic effects of aqueous extract of the fruits of Solanum torvum Swartz (Solanaceae)
George A Koffuor, Patrick Amoateng, Terrick A Andey
Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, Kumasi, Ghana
|Date of Submission||19-Jan-2011|
|Date of Decision||25-Mar-2011|
|Date of Web Publication||8-Jun-2011|
George A Koffuor
Department of Pharmacology, KNUST, Kumasi
Source of Support: George A Koffuor, KNUST, Conflict of Interest: None
| Abstract|| |
Aim: The effect of Solanum torvum (Fam: Solanaceae) on delayed type hypersensitivity (DTH) response, hemagglutinating antibody (HA) titer, white blood cells (WBC), red blood cells (RBC) and hemoglobin concentration was investigated in Sprague-Dawley rats to establish immunomodulatory and erythropoietic activity. Materials and Methods: Sheep red blood cells (SRBC)-immunized and challenged rats were treated with Solanum torvum extract, levamisole and dexamethasone. Phenylhydrazine (PHZ)-induced anemia in rats was treated with the extract. Results: The aqueous Solanum torvum extract and levamisole significantly enhanced DTH response, increased HA titer and WBC count, while dexamethasone significantly decreased DTH response, did not increase HA titer, and did not enhance WBC profile. The extract and Feroglobin, the reference heamatinic, were able to reverse PHZ-induced anemia, and increase the RBCs and Hb concentration above baseline values within 24 days. Conclusion: Solanum torvum extract showed a concentration-dependent immunostimulant and erythropoietic activity.
Keywords: Delayed type hypersensitivity response, hemagglutinating antibody titer, phenylhydrazine, sheep red blood cells, Solanum torvum
|How to cite this article:|
Koffuor GA, Amoateng P, Andey TA. Immunomodulatory and erythropoietic effects of aqueous extract of the fruits of Solanum torvum Swartz (Solanaceae). Phcog Res 2011;3:130-4
|How to cite this URL:|
Koffuor GA, Amoateng P, Andey TA. Immunomodulatory and erythropoietic effects of aqueous extract of the fruits of Solanum torvum Swartz (Solanaceae). Phcog Res [serial online] 2011 [cited 2020 May 31];3:130-4. Available from: http://www.phcogres.com/text.asp?2011/3/2/130/81961
| Introduction|| |
Solanum torvum Swartz (family: Solanaceae) commonly known as turkey berry has been called by several local names such as: Susraba (Ewe), Kwahu Nsusuwa (Kwahu), Yaa Asantewa (Asante Twi), and Seseloatso (Ga-Adamgbe). This plant is found in tropical Africa, Asia and South America. The fruits have been found to contain phytoconstituents such as steroid glycosides and saponins, fixed oil; vitamin B group; vitamin C; iron salts: saponins and steroidal alkaloids.  In Ghana, various parts of the plant have been used either as a haemostatic after childbirth or as a source of saponin for the hemi synthesis of cortisone and sex hormones or for compounding sedatives, diuretics or digestive tonics.  Its leaves have been used in the treatment of abdominal pain, whitlow and whooping cough; its fruits are used in the treatment of anemia, inducing lactation, and treatment of wounds and snakebites.  In most traditional Ghanaian homes, it has become customary to give to mothers, after childbirth, diets containing Solanum torvum fruits with the intention of enhancing vitality and reversing conditions of anemia. Though undocumented, it is generally observed that mothers who eat these fruits show enhanced health status. To date there is little scientific evidence to support the traditional use of S. torvum in the management of anemia and immunodeficiency and the possible mechanisms involved.
The study of agents that modulate the immune system to alleviate certain diseases of immunodeficiency has gained interest. A number of plant materials traditionally administered to mothers after childbirth to overcome the weakness and stress of pregnancy and childbirth, such as dry fruit like almond (Prunus amygdalus) and date palm (Phoenix dactylifera), seeds of Buchanania lanzan and Euryale ferox and dried rhizome of Zingiber officinale, have been shown to possess immunostimulatory properties, thus supporting their traditional uses.  The current study presents an investigation of the immunomodulatory and erythropoietic activities of the fresh fruits of Solanum torvum.
| Materials and Methods|| |
Fruit sample collection
Fresh fruits of Solanum torvum (Fam. Solanaceae), obtained from the local market at Ayigya, Kumasi, were authenticated at the Department of Pharmacognosy, Faculty of Pharmacy, Kwame Nkrumah University of Science and Technology - Ghana. A voucher specimen with number KNUST/HM1/L035 was deposited at the Faculty of Pharmacy's Herbarium, KNUST, Kumasi, Ghana.
Preparation of extract
Six hundred g of fresh S. torvum fruits and 600 ml of distilled water was blended and the homogenous mixture obtained filtered. The filtrate (700 ml) was then evaporated to dryness on a water bath. The dried extract obtained (10 g) was stored and labeled as STE or extract; 1.667% yield was obtained.
Sprague-Dawley rats of either sex (200-215 g) obtained from the animal house of the Department of Pharmacology, KNUST were used. The animals were housed in well-ventilated cages under normal temperature, humidity and light, and fed on normal rat chow (obtained from the animal house) and water ad libitum. All procedures and techniques used in these studies were in accordance with the National Institute of Health Guidelines for the Care and Use of Laboratory Animals (NIH, Department of Health Services publication No. 83-23, revised 1985). The protocols for the study were approved by the Departmental Ethics Committee.
Levamisole 40 mg/ml (Medicore Laboratories Pvt. Ltd, India) was used as the reference immunostimulant whereas dexamethasone sodium phosphate 4 mg/ml (Pharma Inter, Brussels, Belgium) was used as the reference immunosuppressant. Feroglobin; (Vitabiotics Ltd, Great Britain), a liquid tonic containing iron 0.2%, zinc 0.06%, copper 0.02%, manganese 0.025% and vitamin B-Complex 0.39% in a blend of honey and malt, was used as the reference hematinic. Phenylhydrazine (BDH Poole, England) was used to induce anemia.
Sheep blood (Antigen)
For immunization and challenge of the experimental animals, fresh sheep red blood cells (SRBC) obtained from the Kumasi Abattoir Company Ltd, Kumasi were used. Prior to their use, the SRBCs were washed three times in large volumes of 0.9% normal saline, and centrifuged at a speed of 5000 rpm for 10 min. The plasma was decanted and the packed cells obtained were adjusted to a concentration of 5.0 x 10 8 cells/ml with normal saline.
Determination of immunomudulatory activity
Sprague-Dawley rats were put into six groups with six rats in each group. Animals in all groups were immunized with 5.0 x 10 8 SRBC/ml after which each group was treated with either STE (37.5, 75 or 150 mg/kg p.o., daily) based on preliminary investigations, levamisole (10 mg/kg, p.o, daily), dexamethasone sodium (4 mg/kg, i.m., daily) or vehicle.
Delayed type hypersensitivity response
On day 15, the delayed type hypersensitivity (DTH) response was measured as described by Saike et al.,  with modifications. The right hind paw thicknesses of the rats were measured. They were then antigenically challenged by administering 2.5 x 10 7 SRBC /ml, s.c., into the right hind foot pad. The paw thicknesses were again measured after 24 h of challenge and the increase in footpad swelling determined. The increase in paw thickness was used as an index of DTH.
Hemagglutinating antibody titer
On Day 20, the hemagglutinating antibody (HA) titer was determined following the procedure reported by Nelson  with modifications. Blood samples were collected from retro-orbital plexus into test tubes placed on ice. After 1 h, the blood samples were centrifuged to obtain the serum. Ten serial dilutions of the serum in 0.15 M phosphate buffer saline (PBS) pH 7.2 were made and 50 ΅l of these were then titrated with 25 ΅l of 2.5 x 10 7 SRBC /ml. The test tubes were then incubated at room temperature for 2 h and examined visually for agglutination. The reciprocal of the highest dilution of serum showing 50% agglutination is expressed as HA titer.
White blood cell differential count
On Day 28, blood samples obtained from the rats were analyzed for the white cell profile at the Hematology Department, Komfo Anokye Teaching Hospital, Kumasi using the CELL-DYN 1800 auto analyzer. The mean of the results obtained was recorded for each treatment group.
Basal RBC count and hemoglobin concentration of blood were determined for Sprague-Dawley rats. Five of these were put into a group (Group A- normal rats). Anemia was induced using phenylhydrazine (PHZ) (60 mg/kg, i.p., in divided doses daily, for three consecutive days). Anemia was considered induced when RBC level as well as hemoglobin concentration of the blood reduced by about 30%. Anemic rats were put into groups B-F with five per group and treated as follows: (Group B-anemic without treatment, C- Feroglobin 0.15 mg/kg, D, E and F- 37.5, 75, and 150 mg/kg of Solanum torvum extract (STE) respectively daily). The RBC number and hemoglobin concentration were determined using the CELL-DYN 1800 auto analyzer every three days for 24 days.
GraphPad Prism Version 5.0 for Windows (GraphPad Software, San Diego, CA, USA) was used for all statistical analyses. Data are presented as mean ± SEM and analyzed by one-way ANOVA followed by Bonferroni's multiple Comparison test (post test); P ≤ 0.05 was considered statistically significant in all analyses. The graphs were plotted using Sigma Plot for Windows Version 11.0 (Systat Software Inc., Germany).
| Results|| |
The DTH response increased very significantly in groups treated with Levamisole (P < 0.01), and 75 and 150 mg/kg/day S. torvum (P < 0.001) relative to the 'no treatment' group (control). The DTH response for the dexamethasone-treated group decreased significantly (P < 0.05) [Table 1]. Levamisole and Solanum torvum treatment resulted in significant increases (P > 0.001) in the HA titer and WBC count relative to the dexamethasone and 'no treatment' groups [Table 1]. A differential count performed indicated an increase in the neutrophil proportion of the total count in the Solanum -treated groups (75 and 150 mg/kg/day)
|Table 1: Details of the results on delayed type hypersensitivity response, hemagglutinating antibody titer, and white blood cells count|
Click here to view
After induction of anemia, the number of RBCs and the hemoglobin concentration decreased by 58.73% and 64.98% respectively. There was no significant increase (P > 0.05) in the number of RBCs and hemoglobin concentration of the anemic and untreated rats during the experimental period. Treatment of PHZ-induced anemic rats with the reference hematinic (0.15 ml/kg), and Solanum torvum (37.5-150 mg/kg) resulted in significant increase (P < 0.001) in both, the number of RBCs and hemoglobin concentration as compared to the untreated PHZ-induced anemic rats [Figure 1] and [Figure 2]. Difference between treatment groups was however insignificant (P > 0.05). Area under the curve (AUC) values for these are as shown in the [Table 2]. As the anemic condition improves the AUC value increases.
|Figure 1: The relationship between the red blood cells count (per mm3 of blood) and time (days) for normal Sprague-Dawley rats, rats in whom anemia has been induced with Phenylhydrazine but not treated, and those in whom anemia has been induced and treated with either a reference hematinic, or three different doses of Solanum torvum extract. Values are means ± s.e.m. (n=6). **P < 0.01, ***P < 0.001 compared to vehicle-treated group (Two-way ANOVA followed by Bonferroni's post hoc test)|
Click here to view
|Figure 2: The relationship between the hemoglobin concentration (g/dl) and time (days) for normal Sprague-Dawley rats, rats in whom anemia has been induced with Phenylhydrazine but not treated, and those in whom anemia has been induced and treated with either a reference hematinic, or three different doses of Solanum torvum extract. Values are means ± s.e.m. (n=6). **P < 0.01, ***P < 0.001 compared to vehicletreated group (Two-way ANOVA followed by Bonferroni's post hoc test)|
Click here to view
|Table 2: The area under the curve values obtained from curves of the mean red blood cell counts, and the mean hemoglobin concentration against time for different treatment groups|
Click here to view
| Discussion|| |
The extract significantly and dose-dependently increased the DTH response, which is a direct correlate of cell-mediated immunity (CMI). A similar effect was observed for levamisole. DTH is a Type IV reaction characterized by large influxes of non-specific inflammatory cells, particularly macrophages leading to the activation of sensitized T DTH cells. Activation of T DTH cells by antigens results in the secretion of various cytokines including interleukin-2, interferon-γ, macrophage migration inhibition factor and tumor necrosis factor-β and subsequent phagocytic activity. There is evidence to suggest that DTH reaction is important in host defense against parasites and bacteria that can live and proliferate intracellularly.  Treatment of STE enhanced DTH reaction, which is reflected from the increased footpad thickness compared to the control group suggesting heightened infiltration of macrophages to the inflammatory site. This study may support a possible role of STE in promoting cell-mediated immune response. The DTH response for the dexamethasone-treated group decreased significantly (P < 0.05) as expected of immunosuppressants.
The Solanum torvum extract and levamisole significantly increased the HA titer compared to dexamethasone and the control groups. The HA titer was determined to establish the humoral response against SRBC by STE. An increase in HA titer indicates that there has been a proliferation of antibodies (a large dilution of the serum still contains enough antibodies to engage in antigen-antibody reaction) which enhances or boosts the immune system. At neutral pH, RBCs possess a negative ions' cloud that makes the cells repel one another, this repulsive force is referred to as zeta potential. Because of its size and pentameric nature, immunoglobulin M (IgM ) can overcome the electric barrier and get cross-link RBCs, leading to subsequent agglutination. The smaller size and bivalency of immunoglobulin G (IgG), however, makes them less capable of overcoming the electric barrier. This characteristic may account for IgM being more effective than IgG in agglutinating red blood cells.  STE treatment improved the HA titer reflecting an overall elevation of humoral immune response
The extract and levamisole treatment resulted in significant increases (P > 0.001) in the WBC count relative to the dexamethasone and 'no treatment' groups. A differential count performed indicated an increase in the neutrophil proportion of the total count in the Solanum -treated groups. The augmentation of the humoral response as evidenced by an enhancement of antibody responsiveness to SRBC as a consequence of both pre- and post-immunization drug treatment indicates the enhanced responsiveness of macrophages and B-lymphocyte subsets involved in antibody synthesis. Since neutrophils account for 50-70% of WBCs, it can be said that the neutrophil production increased with increasing white cell production. The neutrophils provide the major defense against pyogenic (pus-forming) bacteria and are the first on the scene to fight infection. This suggests that the innate immunity was enhanced by Solanum torvum. This effect may probably be due to its high vitamin B complex and vitamin C content since vitamins are known to boost the body's immune system.
STE and the reference hematinic caused a steady and dose-dependent increase in the number of RBCs and hemoglobin concentration in the PHZ-induced anemic rats in comparison to the untreated anemic rats. Phenylhydrazine induces hemolysis of RBCs by inducing the formation of toxic, free radicals that can attack cellular macromolecules like hemoglobin resulting in oxidative damage within the RBCs resulting in their destruction. , Again, an attack by free radicals accelerates the normal aging process of the red cells causing premature splenic sequestration. This results in a quantitative deficiency of circulating RBCs and hence hemoglobin.  There was no significant increase (P > 0.05) in the number of RBCs and the hemoglobin concentration of the anemic but untreated rats during the experimental period. Tissue hypoxia which could be caused by a quantitative deficiency of circulating RBCs and hemoglobin was not enough to bring the RBC number and hemoglobin concentration back to the original levels (as was observed in the rats which were not treated after induction of PHZ-anemia). Tissue hypoxia stimulates the erythropoietin-producing cells in the kidney to produce erythropoietin which is a hormone that regulates the proliferation and differentiation of hematopoietic progenitor cells in the bone marrow of all the anemic rats.  This results in the correction of anemia provided that the bone marrow response is not impaired by red-cell nutritional deficiency (especially iron deficiency).
The reference hematinic contains iron which forms the nucleus of the iron-porphyrin haem ring and together with globin chains forms hemoglobin. The vitamin B complex vitamins act as precursor in the synthesis of cofactors for hematopoiesis and protein synthesis.  Solanum torvum (also known as vitamin B complex fruit) has as part of its chemical constituents, steroids, glycosides, saponins, fixed oils, vitamin B group, and iron salts.  This may account for its ability to reverse anemia comparable to that of the reference hematinic. S. torvum also contains vitamin C which may help in the reduction of iron in the ferric state to the ferrous state resulting in the rapid absorption of iron which will increase hemoglobin synthesis.  The exact mechanisms by which the extract exhibited the reported effects need further mechanistic investigations.
| Conclusion|| |
The aqueous extract of Solanum torvum possesses immunomodulatory and hematinic properties thus supporting its traditional uses as a hematinic and as food for the patients with reduced immunity.
| Acknowledgments|| |
The authors wish to express their gratitude to the following: Godfred Amedzro, Sheila Baah-Frimpong and Linda Asare-Adjebeng for assisting in the laboratory work.
This research project was conducted from August 2008 to April 2009. This project was entirely funded by George A Koffuor. Equipment and a few chemicals used were obtained from the Department of Pharmacology, KNUST.
| References|| |
|1.||Ghana Herbal Pharmacopoeia. 2 edn. Ghana: Science and Technology Policy Research Institute; Accra. 2007. p 221-5. |
|2.||Puri A, Sahai R, Singh KL, Saxena RP, Tandon JS, Saxena KC. Immunostimulant activity of dry fruits and plant materials used in Indian traditional medical system for mothers after child birth and invalids. J Ethnopharmacol 2000;71:89-92. |
|3.||Saike I, Tanio Y, Yamawaki M, Kobayashi S, Fukuda T, Yukimasa H, et al. Adjuvant activity of quinonyl-Nacetyl muranyl dipeptides in mice and guinea pigs. Infect Immun 1981;31:114-21. |
|4.||Nelson DS, Mildenhall P. Studies on cytophilic antibodies: 1, The production by mice of macrophage cytophilic antibodies to sheep erythrocytes: Relationship to the production of other antibodies and development of delayed type hypersensitivity. Aust J Exp Biol Med Sci 1967;45:113-30. |
|5.||Askenase PW, Van Loveren M. Delayed type hypersensitivity: Activation of mast cells by antigen specific T-cell factors initiates cascade of cellular interactions. Immunol Today 1983;4:259-64. |
|6.||Tiwari U, Rastogi B, Singh P, Saraf DK, Vyas SP. Immunomodulatory effects of aqueous extract of Tridax procumbens in experimental animals. J Ethnopharmacol 2004;92:113-9. |
|7.||Kuby J. Immunology. 2 nd ed. New York: Freeman and Company; 1994. ISBN 0716724006. |
|8.||Jain SK, Hochstein P. Generation of superoxide radicals by hydrazine: Its role in phenylhydrazine-induced hemolytic anemia. Biochim Biophysica Acta 1979;586:128-36. |
|9.||Jain SK, Subrahmanyam D. On the mechanism of phenylhydrazine-induced hemolytic anemia. Biochemical and Biophysical Research Communications 1978;82:1320-4. |
|10.||Magnani M, Rossi L, Cucchiarini L, Stocchi V, Fornaini G. Effect of phenylhydrazine on red blood cell metabolism. Cell Biochem Funct 1988;6:175-82. |
|11.||Craig CR, Stitzel RE. Modern Pharmacology. 2 nd ed. Boston: Little Brown and Company; 1986. p. 1074-5. |
|12.||Padayatty SJ, Katz A, Wang Y, Eck P, Kwon O, Lee J, et al. Vitamin C as an antioxidant: evaluation of its role in disease prevention. JAm Coll Nutr 2003;22:18-35. |
[Figure 1], [Figure 2]
[Table 1], [Table 2]
|This article has been cited by|
||Phyllanthin from Phyllanthus amarus inhibits cellular and humoral immune responses in Balb/C mice
| ||Menaga Ilangkovan,Ibrahim Jantan,Syed Nasir Abbas Bukhari |
| ||Phytomedicine. 2016; 23(12): 1441 |
|[Pubmed] | [DOI]|
||Inhibitory Effects of the Standardized Extract ofPhyllanthus amaruson Cellular and Humoral Immune Responses in Balb/C Mice
| ||Menaga Ilangkovan,Ibrahim Jantan,Mohamed Ahmed Mesaik,Syed Nasir Abbas Bukhari |
| ||Phytotherapy Research. 2016; |
|[Pubmed] | [DOI]|
||Hematopoietic Effect ofAmaranthus cruentusExtract on Phenylhydrazine-Induced Toxicity in Rats
| ||Stuti Pandey,Aditya Ganeshpurkar,Divya Bansal,Nazneen Dubey |
| ||Journal of Dietary Supplements. 2016; : 1 |
|[Pubmed] | [DOI]|
||Effects of organic extracts of six Bangladeshi plants on in vitro thrombolysis and cytotoxicity
| ||M Atiar Rahman,Rabeya Sultana,Talha Bin Emran,M Saiful Islam,M Ashiqur Rahman,Joti Sankhar Chakma,Harun-ur Rashid,Chowdhury Mohammad Monirul Hasan |
| ||BMC Complementary and Alternative Medicine. 2013; 13(1) |
|[Pubmed] | [DOI]|
||Immunostimulatory and biochemical effects of ethanolic extract of Mangiferaindica stem bark on dexamethasone-induced immunosuppressed male rats
| ||Grace, U. and Steve, O. and Teddy, E. and Shakirat, B. |
| ||International Journal of Pharmacy and Pharmaceutical Sciences. 2013; 5(SUPPL. 2): 569-572 |
||Effects of organic extracts of six Bangladeshi plants on in vitro thrombolysis and cytotoxicity
| ||Rahman, M.A. and Sultana, R. and Bin Emran, T. and Islam, M.S. and Rahman, M.A. and Chakma, J.S. and Rashid, H.-U. and Hasan, C.M.M. |
| ||BMC Complementary and Alternative Medicine. 2013; 13(25) |
||Solanum torvum: A review of its traditional uses, phytochemistry and pharmacology
| ||Jaiswal, B.S. |
| ||International Journal of Pharma and Bio Sciences. 2012; 3(4): 104-111 |